טוען...
Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy
PURPOSE: To investigate the 2-year outcomes of three monthly intravitreal ranibizumab injections followed by as-needed reinjections to treat polypoidal choroidal vasculopathy (PCV). METHODS: Seventy-five consecutive eyes with naïve symptomatic PCV with 2 years of follow-up after treatment were studi...
שמור ב:
| Main Authors: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3632979/ https://ncbi.nlm.nih.gov/pubmed/23428984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2012-302652 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|